Renlong Zou

482 total citations
20 papers, 313 citations indexed

About

Renlong Zou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Renlong Zou has authored 20 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Renlong Zou's work include Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Renlong Zou is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Renlong Zou collaborates with scholars based in China, South Korea and Japan. Renlong Zou's co-authors include Yue Zhao, Shengli Wang, Tingting Zhou, Ge Sun, Ning Sun, Y. Gao, Yifu Guan, Haiyan Zhang, Xin Meng and Hua‐Qin Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Cell Death and Differentiation.

In The Last Decade

Renlong Zou

20 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renlong Zou China 10 249 73 41 34 28 20 313
Stefania Pieroni Italy 11 194 0.8× 70 1.0× 74 1.8× 32 0.9× 18 0.6× 21 284
Xianle Shi China 6 194 0.8× 76 1.0× 78 1.9× 46 1.4× 21 0.8× 10 311
Naoko Nakano Japan 9 241 1.0× 58 0.8× 56 1.4× 47 1.4× 18 0.6× 10 308
Julia W. Grimstead United Kingdom 12 256 1.0× 58 0.8× 26 0.6× 18 0.5× 20 0.7× 20 420
Emma Johnson United Kingdom 4 152 0.6× 92 1.3× 37 0.9× 34 1.0× 14 0.5× 11 234
Laurensia Yuniati Netherlands 6 240 1.0× 55 0.8× 44 1.1× 18 0.5× 12 0.4× 9 311
Raymond Che United States 8 275 1.1× 55 0.8× 70 1.7× 25 0.7× 48 1.7× 8 315
Chie Yamaguchi Japan 6 340 1.4× 59 0.8× 35 0.9× 37 1.1× 57 2.0× 6 418
Carlos Benitéz‐Buelga Spain 9 193 0.8× 40 0.5× 25 0.6× 28 0.8× 25 0.9× 15 293
Guoying Miao China 7 150 0.6× 71 1.0× 51 1.2× 25 0.7× 18 0.6× 12 230

Countries citing papers authored by Renlong Zou

Since Specialization
Citations

This map shows the geographic impact of Renlong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renlong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renlong Zou more than expected).

Fields of papers citing papers by Renlong Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renlong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renlong Zou. The network helps show where Renlong Zou may publish in the future.

Co-authorship network of co-authors of Renlong Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Renlong Zou. A scholar is included among the top collaborators of Renlong Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renlong Zou. Renlong Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xue, Guangqi Yan, Hao Li, et al.. (2025). RBAP48 facilitates the oral squamous cell carcinoma process in an androgen receptor-dependent and independent manners. Communications Biology. 8(1). 829–829. 1 indexed citations
2.
Liu, Wensu, Tianyu Tang, Chunyu Wang, et al.. (2024). Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen. Journal of Ovarian Research. 17(1). 38–38. 3 indexed citations
3.
Zeng, Kai, Weiwen Xie, Chunyu Wang, et al.. (2023). USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell Death and Disease. 14(3). 194–194. 11 indexed citations
4.
Jin, Zining, Qingfu Zhang, Chunyu Wang, et al.. (2022). High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer. Acta Biochimica et Biophysica Sinica. 54(7). 1034–1038. 1 indexed citations
5.
Zeng, Kai, Shuchang Liu, Yi Wu, et al.. (2022). Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer. Journal of Biological Chemistry. 299(1). 102734–102734. 6 indexed citations
6.
Sun, Ge, Manlin Wang, Yu Bai, et al.. (2022). The BAP18/CTCF/NURF Complex Contributes to Modulation of Enhancer RNAs and Endocrine Resistance in Breast Cancer. SSRN Electronic Journal. 1 indexed citations
7.
Tang, Tianyu, Jiao Jiao, Da Li, et al.. (2021). The function of BAP18 on modulation of androgen receptor action in luteinized granulosa cells from normal weight women with and without PCOS. Molecular and Cellular Endocrinology. 527. 111228–111228. 6 indexed citations
8.
Shan, Wei, Wei Liu, Ning Sun, et al.. (2021). MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma. Cancer Science. 112(5). 1865–1877. 18 indexed citations
9.
Wang, Xue, Chunyu Wang, Guangqi Yan, et al.. (2020). BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma. EBioMedicine. 53. 102685–102685. 10 indexed citations
10.
Sun, Ning, Xinping Zhong, Shengli Wang, et al.. (2020). ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function. EBioMedicine. 62. 103108–103108. 9 indexed citations
11.
Wang, Shengli, Xinping Zhong, Chunyu Wang, et al.. (2020). USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer. Cell Death and Differentiation. 27(11). 3131–3145. 33 indexed citations
12.
Liu, Wei, Chunyu Wang, Shengli Wang, et al.. (2020). PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells. International Journal of Biological Sciences. 17(1). 188–203. 8 indexed citations
13.
Zeng, Kai, Yi Wu, Chunyu Wang, et al.. (2020). ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription. Cancer Science. 111(6). 2062–2077. 17 indexed citations
14.
Sun, Ge, Chunyu Wang, Shengli Wang, et al.. (2020). An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer. Nucleic Acids Research. 48(19). 10768–10784. 13 indexed citations
15.
Zhong, Xinping, Chunyu Wang, Shengli Wang, et al.. (2016). SNF5 is Involved in Suppression of Hepatocellular Carcinoma Progression via TGF‐Beta 1 Signaling. The Anatomical Record. 299(7). 869–877. 7 indexed citations
16.
Zhong, Xinping, Chunyu Wang, Shengli Wang, et al.. (2016). BAP18 coactivates androgen receptor action and promotes prostate cancer progression. Nucleic Acids Research. 44(17). 8112–8128. 24 indexed citations
17.
Wang, Chunyu, Renlong Zou, Tingting Zhou, et al.. (2015). MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Nucleic Acids Research. 43(10). 4893–4908. 45 indexed citations
18.
Zou, Renlong, Xinping Zhong, Chunyu Wang, et al.. (2015). MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression. International Journal of Biological Sciences. 11(9). 992–1005. 30 indexed citations
19.
Zhou, Tingting, Renlong Zou, Shengli Wang, et al.. (2012). Identification of endocrine disrupting chemicals activating SXR-mediated transactivation of CYP3A and CYP7A1. Molecular and Cellular Endocrinology. 365(1). 36–43. 7 indexed citations
20.
Du, Zhen‐Xian, Haiyan Zhang, Xin Meng, et al.. (2008). Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1. Journal of Cellular Physiology. 218(3). 631–637. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Pieroni Breakdown of academic impact, for papers by Xianle Shi Breakdown of academic impact, for papers by Naoko Nakano Breakdown of academic impact, for papers by Julia W. Grimstead Breakdown of academic impact, for papers by Emma Johnson Breakdown of academic impact, for papers by Laurensia Yuniati Breakdown of academic impact, for papers by Raymond Che Breakdown of academic impact, for papers by Chie Yamaguchi Breakdown of academic impact, for papers by Carlos Benitéz‐Buelga Breakdown of academic impact, for papers by Guoying Miao
Rankless by CCL
2026